CLINICAL CHARACTERISTICS, DIAGNOSIS, AND IMPACT ON EMPLOYMENT IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM A REAL-WORLD SURVEY IN CANADA

被引:0
|
作者
Lowe, M. [1 ]
Jackson, J. [1 ]
Zhong, Y. [2 ]
Contente, M. [3 ]
Le, Brocq L. [1 ]
Patel, H. [4 ]
Barlow, S. [1 ]
Krause, T. [5 ]
机构
[1] Adelphi Real World, Bollington, Cheshire, England
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Bristol Myers Squibb, Uxbridge, Middx, England
[4] Bristol Myers Squibb, Quebec City, PQ, Canada
[5] Bristol Myers Squibb, London, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
CO114
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [1] DEMOGRAPHICS OF PATIENTS AND SOCIETAL BURDEN OF OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM A REAL-WORLD SURVEY IN ITALY AND SPAIN
    Lowe, M.
    Jackson, J.
    Tebbs, K.
    Zhong, Y.
    Contente, M.
    Barlow, S.
    Krause, T.
    VALUE IN HEALTH, 2023, 26 (12) : S5 - S5
  • [2] Clinical characteristics and burden of non-obstructive hypertrophic cardiomyopathy: a real-world survey in Italy and Spain
    Lowe, M.
    Jackson, J.
    Zhong, Y.
    Contente, M.
    Le Brocq, L.
    Barlow, S.
    Krause, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [3] Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices
    Butzner, Michael
    Sarocco, Phil
    Maron, Martin S.
    Rowin, Ethan
    Teng, Chia-Chen
    Stanek, Eric
    Tan, Hiangkiat
    Robertson, Laura A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 174 : 120 - 125
  • [4] Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy
    Maurizi, Niccolo
    Chiriatti, Chiara
    Fumagalli, Carlo
    Targetti, Mattia
    Passantino, Silvia
    Antiochos, Panagiotis
    Skalidis, Ioannis
    Chiti, Chiara
    Biagioni, Giulia
    Tomberli, Alessia
    Giovani, Sara
    Coppini, Raffaele
    Cecchi, Franco
    Olivotto, Iacopo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [5] Real-World Adherence to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in the United States
    Masri, Ahmad
    Hernandez, Ervant J. Maksabedian
    Wang, Yan
    Gao, Weihua
    Wu, Aozhou
    Han, Xu
    CIRCULATION, 2023, 148
  • [6] Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population
    Bertero, Edoardo
    Chiti, Chiara
    Schiavo, Maria Alessandra
    Tini, Giacomo
    Costa, Paolo
    Todiere, Giancarlo
    Mabritto, Barbara
    Dei, Lorenzo-Lupo
    Giannattasio, Alessia
    Mariani, Davide
    Lofiego, Carla
    Santolamazza, Caterina
    Monda, Emanuele
    Quarta, Giovanni
    Barbisan, Davide
    Mandoli, Giulia Elena
    Mapelli, Massimo
    Sguazzotti, Maurizio
    Negri, Francesco
    De Vecchi, Simona
    Ciabatti, Michele
    Tomasoni, Daniela
    Mazzanti, Andrea
    Marzo, Francesca
    de Gregorio, Cesare
    Raineri, Claudia
    Vianello, Pier Filippo
    Marchi, Alberto
    Biagioni, Giulia
    Insinna, Eleonora
    Parisi, Vanda
    Ditaranto, Raffaello
    Barison, Andrea
    Giammarresi, Andrea
    De Ferrari, Gaetano Maria
    Priori, Silvia
    Metra, Marco
    Pieroni, Maurizio
    Patti, Giuseppe
    Imazio, Massimo
    Perugini, Enrica
    Agostoni, Piergiuseppe
    Cameli, Matteo
    Merlo, Marco
    Sinagra, Gianfranco
    Senni, Michele
    Limongelli, Giuseppe
    Ammirati, Enrico
    Vagnarelli, Fabio
    Crotti, Lia
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (01) : 59 - 64
  • [7] Real-World Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: A US Single Center Experience
    Reza, Nosheen
    Dubey, Anand
    Carattini, Thomas
    Maya, Juan
    Ferri, Mauricio
    Botros, Afraim
    Marzolf, Amy
    Hornsby, Nicole
    de Feria, Alejandro
    Owens, Anjali T.
    CIRCULATION, 2023, 148
  • [8] Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center
    Desai, Milind Y.
    Hajj-Ali, Adel
    Rutkowski, Katy
    Ospina, Susan
    Gaballa, Andrew
    Emery, Michael
    Asher, Craig
    Xu, Bo
    Thamilarasan, Maran
    Popovic, Zoran B.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 86 : 62 - 68
  • [9] Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: observations from a tertiary care center
    Desai, M.
    Hajj-Ali, A.
    Rutkowski, K.
    Ospina, S.
    Gaballa, A.
    Emery, M.
    Asher, C.
    Xu, B.
    Thamilarasan, M.
    Popovic, Z.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] "REAL-WORLD" USE OF MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN ACADEMIC CENTER
    Chandrasekhar, Sanjay Amrith
    Cornelio, Cyrille
    Miranda, Aimon Chantara
    Wu, Robby
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 680 - 680